Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions.
Improving the quality of life and reducing sudden cardiac death by limiting the impact of heart rhythm disturbances.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
The primary objective of this worldwide registry on PPCM is to establish the clinical epidemiology and the diagnostic/therapeutic processes of women suffering from this condition, as well as the collection of information on their offspring.
Data will be collected on possible risk factors, diagnosis, mode of delivery, standard management and therapeutic interventions currently performed in each centre for patients presenting with signs and symptoms of PPCM pre- or postpartum. Drug prescriptions and indications to perform diagnostic/therapeutic procedures will be completely left to the participating cardiologist’s decision. No specific protocols or recommendations for evaluation, management, and/or treatment will be put forth during this observational study. Data on 6 and 12 month maternal outcome will be collected. The mandatory key questions qualifying a patient likely to have the diagnosis of PPCM are: Peripartum stage, Signs and/or symptoms of heart failure, Ejection fraction <45%. Retrospective patients can be enrolled up to 6 months from the start of the registry.To receive information on how to participate in this registry, please contact the EURObservational Research Programme via the contact form.
Fill in the contact form
Participating centres could consider participating in related PPCM companion studies on genetics, biomarkers and device therapy.
This registry is "centre-based" and is conducted by an Executive Committee consisting of scientific experts.The Executive Committee is chaired by Karen Sliwa and Johann Bauersachs.
Karen Sliwa, Co-ChairJohann Bauersachs, Co-ChairKatrin BachelierUri ElkayamRoger HallDenise Hilfiker-KleinerAldo Pietro MaggioniJohn McMurrayAlexandre MebazaaFrederic MouquetMark PetriePiotr PonikowskiVera Regitz-ZagrosekJolien Roos-HesselinkMaria SchaufelbergerPetar SeferovicAjay ShahLuigi TavazziKarin van Spaendonck-ZwartDirk van Veldhuisen
© 2017 European Society of Cardiology. All rights reserved